subject: CHEBI:76128

object_name: pain agnosia


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Pain insensitivity

tested_intervention: yes


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stomach cancer

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:131769963

object_name: gastric cancer


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: acute respiratory distress syndrome


subject: CHEBI:16480

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0127159

subject_name: MCI 186

object_name: amyotrophic lateral sclerosis


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Plexosarcoma


subject: UMLS:C0919079

object_name: cancer


subject: UMLS:C0919079

object_name: neoplasm


subject: UMLS:C0919079

object_name: Subdural hemorrhage


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UNII:SJ5A8151JO

object_name: Inflammation


subject: UNII:SJ5A8151JO

object_name: HIV infection


subject: UNII:SJ5A8151JO

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Carcinoma liver resectable


subject: CHEBI:194425

subject_name: Lobaplatin


subject: CHEMBL.COMPOUND:CHEMBL2068623


subject: CHEBI:192744

subject_name: lobaplatin


subject: CHEBI:5847

subject_name: Raltitrexed


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:76607

subject_name: Macitentan

object_name: Lung transplant rejection


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: wet macular degeneration


subject: PUBCHEM.COMPOUND:135405876

subject_name: Folate

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: PUBCHEM.COMPOUND:135405876

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:135405876

object_name: thrombocytopenia


subject: PUBCHEM.COMPOUND:135405876

object_name: leukopenia


subject: PUBCHEM.COMPOUND:135405876

object_name: neutropenia


subject: PUBCHEM.COMPOUND:135405876

object_name: anemia


subject: PUBCHEM.COMPOUND:135405876

object_name: Anemia, CTCAE


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:62501


subject: CHEBI:37445

subject_name: folic acids


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: CHEBI:37445


subject: UMLS:C0178638

subject_name: folate


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: UMLS:C0178638


subject: CHEBI:67011

subject_name: folates


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:67011


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: UMLS:C4744969

subject_name: Micro Needle Array-Doxorubicin

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C4744969

object_name: primary cutaneous T-cell lymphoma


subject: UNII:CA67JF5Q4W

object_name: Agitation on recovery from sedation


subject: CHEBI:5818

subject_name: Hydroxyzine


subject: UMLS:C0540301

subject_name: C1 esterase inhibitor

object_name: hereditary angioedema


subject: UMLS:C0009500

subject_name: Complement C1 Inactivator Proteins


subject: PUBCHEM.COMPOUND:168346974

subject_name: -Epicatechin

object_name: Prediabetes


subject: UMLS:C2974550

object_name: chronic hepatitis C virus infection


subject: UNII:58BU988K90

subject_name: Deleobuvir


subject: UMLS:C3886693


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:27999

subject_name: Tolbutamide


subject: CHEBI:42588

subject_name: Fenretinide

object_name: Prostate cancer recurrent


subject: CHEBI:42588

object_name: prostate adenocarcinoma


subject: CHEBI:94366

subject_name: itraconazole

object_name: oral candidiasis


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: macular degeneration


subject: UMLS:C3534685

object_name: age-related macular degeneration


subject: UMLS:C3534685

object_name: retinitis pigmentosa 30


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UMLS:C5203181


subject: UMLS:C5203181


subject: CHEBI:45783

subject_name: Imatinib

object_name: loiasis


subject: MESH:C000727548

object_name: esophageal cancer


subject: MESH:C000727548

object_name: colorectal cancer


subject: MESH:C000727548

object_name: colorectal carcinoma


subject: MESH:C000727548

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: MESH:C000727548

object_name: Stomach cancer


subject: MESH:C000727548

object_name: gastric cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Diffuse large B-cell lymphoma, unclassifiable, NOS


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C4733411

subject_name: Regular Novolin R

object_name: Parkinson disease


subject: CHEBI:34605

object_name: schizophrenia


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: pulmonary embolism


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Neurogenic detrusor overactivity


subject: CHEBI:7476

subject_name: Naproxen

object_name: Disorder of Achilles tendon


subject: CHEBI:7476

object_name: Tendon Injuries


subject: CHEBI:7476

object_name: Inflammation


subject: CHEBI:8713

subject_name: Quinapril

object_name: diabetes mellitus


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: liver cirrhosis


subject: UMLS:C5418770

subject_name: Oligo-fucoidan

object_name: digestive system cancer


subject: UMLS:C5418770

object_name: female reproductive organ cancer


subject: CHEBI:145499

subject_name: Donepezil

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:145499

object_name: Delayed cerebral ischaemia


subject: CHEBI:145499

object_name: Vasospasm


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: opiate dependence


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: prostate carcinoma


subject: UMLS:C5544338


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Sepsis


subject: CHEBI:94518

object_name: Sepsis, CTCAE


subject: CHEBI:94518

object_name: septic shock


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:36088


subject: PUBCHEM.COMPOUND:129627881

subject_name: Noac

object_name: Nonvalvular atrial fibrillation


subject: CHEBI:231132

subject_name: N(4)-Oleylcytosine arabinoside


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant


subject: CHEBI:2181

subject_name: L-fucopyranose

object_name: leukocyte adhesion deficiency type II


subject: CHEBI:48204

subject_name: Fucose


subject: CHEBI:42548

subject_name: alpha-L-fucose


subject: CHEBI:18287

subject_name: L-fucose


subject: CHEBI:3611

subject_name: Chlordiazepoxide

object_name: Chest pain


subject: CHEBI:27436

subject_name: Methyltestosterone

object_name: Menopause present (finding)


subject: CHEBI:27436

object_name: Menopause


subject: UNII:9P1872D4OL

subject_name: Exenatide

object_name: cocaine use disorder


subject: CHEBI:95165

object_name: ovarian cancer


subject: CHEBI:95165

object_name: ovarian neoplasm


subject: CHEBI:95165

object_name: ovarian carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:49086

object_name: Premature birth


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: type 1 diabetes mellitus


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: GTOPDB:13497

subject_name: axatilimab

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:13497

object_name: PALB2 Hereditary Breast Carcinoma


subject: GTOPDB:13497

object_name: BRCA1 gene mutation


subject: GTOPDB:13497

object_name: BRCA2 gene mutation


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:91367

object_name: myeloid leukemia


subject: UMLS:C1831923


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Neoplasm Metastasis


subject: UMLS:C2826229


subject: CHEBI:132082

subject_name: Entinostat

object_name: fallopian tube carcinoma


subject: CHEBI:132082

object_name: fallopian tube cancer


subject: CHEBI:132082

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:132082

object_name: Recurrent ovarian cancer


subject: CHEBI:132082

object_name: fallopian tube carcinosarcoma


subject: CHEBI:132082

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:132082

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:132082

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:132082

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:132082

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:132082

object_name: Recurrent Endometrial Cancer


subject: CHEBI:132082

object_name: ovarian carcinosarcoma


subject: CHEBI:132082

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:132082

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:132082

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: acquired aplastic anemia


subject: UMLS:C5239484

subject_name: Mikei Red Reishi Essence EX

object_name: prostate carcinoma


subject: UMLS:C5239484

object_name: prostate cancer


subject: CHEBI:45783

subject_name: Imatinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: myeloproliferative neoplasm


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:367163

subject_name: Darunavir

object_name: AIDS dementia


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: malignant soft tissue neoplasm


subject: CHEBI:59495

object_name: sarcoma


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: PR:000023739

subject_name: L-rhamnose-proton symporter

object_name: hereditary antithrombin deficiency


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: anemia


subject: CHEBI:45863

object_name: Anemia, CTCAE


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:74757

subject_name: Pro-Gln

object_name: malaria


subject: UMLS:C3827191

subject_name: AvidinOX

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: RXCUI:1942744

subject_name: Vyxeos


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: Rhinoconjunctivitis


subject: UniProtKB:P19726

object_name: Atopic rhinitis


subject: UniProtKB:P19726

object_name: allergic asthma


subject: UMLS:C1567931

subject_name: Macugen

object_name: age-related macular degeneration


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:5931

subject_name: insulin human

object_name: glucose intolerance


subject: CHEBI:5931

object_name: Impaired glucose tolerance


subject: CHEBI:5931

object_name: Macrosomia


subject: UMLS:C0123677

subject_name: NovoLog

object_name: Prediabetes


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: UMLS:C4721874

subject_name: human insulin


subject: UMLS:C4721874


subject: UMLS:C4721874


subject: UMLS:C4721874


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C0306371


subject: UMLS:C5435461

object_name: tuberculosis


subject: UMLS:C0733741

subject_name: Microgynon


subject: CHEBI:173763

subject_name: Thermophillin

object_name: cocaine abuse


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: UNII:PT4P8MJP8L

subject_name: Tavapadon

object_name: Hepatic impairment


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:15927

object_name: COPD, severe early onset


subject: CHEBI:15927

object_name: chronic obstructive pulmonary disease


subject: UNII:B6840JH4EB

subject_name: BATIRAXCEPT

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C4733686


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Symptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:31781

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:31781

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:31781

object_name: Malignant Solid Neoplasm


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:45409


subject: MESH:C000627770

subject_name: folfirinox

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:66910

subject_name: Axitinib

object_name: solitary fibrous tumor


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:2453

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:2453

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:2453

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:2453

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: PUBCHEM.COMPOUND:73005958


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: CHEBI:28445

subject_name: vincristine


subject: UNII:V8ZG4Y1B51

subject_name: TALABOSTAT MESYLATE

object_name: renal carcinoma


subject: UNII:V8ZG4Y1B51

object_name: kidney neoplasm


subject: UNII:V8ZG4Y1B51

object_name: kidney cancer


subject: UMLS:C1311786

subject_name: PT-100 dipeptide


subject: UMLS:C1311786


subject: UMLS:C1311786


subject: UMLS:C5435006

object_name: Prodromal Alzheimer's disease


subject: UMLS:C0732248

subject_name: Priorix

object_name: mumps


subject: UMLS:C0732248

object_name: measles


subject: UMLS:C0732248

object_name: rubella


subject: CHEBI:32139

object_name: coronary artery disorder


subject: CHEBI:32139

object_name: coronary atherosclerosis


subject: CHEBI:91899

object_name: radiation proctitis


subject: CHEBI:3207

subject_name: Budesonide


subject: MESH:C512413

subject_name: nanocis

object_name: ovarian cancer


subject: MESH:C512413

object_name: ovarian neoplasm


subject: MESH:C512413

object_name: ovarian carcinoma


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: laryngeal disorder


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: hypopharynx squamous cell carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:73662

subject_name: Thr-Pro

object_name: laryngeal carcinoma


subject: CHEBI:73662


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000029585


subject: PR:000009721


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: PR:000016875


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UMLS:C5444129


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:156342

subject_name: Arg-Asp-Asp

object_name: plasma cell myeloma


subject: CHEBI:156342

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5448047

subject_name: STP 705

object_name: squamous carcinoma in situ


subject: CHEBI:74705

subject_name: Met-Leu

object_name: cardiovascular disorder


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:135905

subject_name: Terlipressin

object_name: acute kidney failure


subject: CHEBI:135905

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:135905

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:135905

object_name: acute-on-chronic liver failure


subject: CHEBI:2038

subject_name: Azacitidine

object_name: neoplasm


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Thalassemia Intermedia


subject: CHEBI:50217

subject_name: selegiline

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: uterine corpus cancer


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C2700362

subject_name: Lymphoseek

object_name: endometrial cancer


subject: UMLS:C2700362


subject: UMLS:C2700362

object_name: endometrial carcinoma


subject: UMLS:C2981819

object_name: Advanced Cholangiocarcinoma


subject: UMLS:C2981819

object_name: FGFR2 Gene Mutation


subject: CHEBI:63451

subject_name: Infigratinib


subject: CHEBI:63451


subject: CHEBI:47426

subject_name: Furosemide

object_name: Acute Heart Failure Related to COVID-19


subject: CHEBI:47426

object_name: Acute heart failure


subject: CHEBI:47426

object_name: chronic kidney disease


subject: CHEBI:181906

subject_name: Polydextrose

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:181906

object_name: obesity


subject: CHEBI:181906

object_name: Obesity, CTCAE


subject: CHEBI:181906

object_name: type 2 diabetes mellitus


subject: CHEBI:181906

object_name: Insulin resistance


subject: CHEBI:181906

object_name: hyperglycemia


subject: CHEBI:181906

object_name: Hyperglycemia, CTCAE


subject: CHEBI:181906

object_name: Glucose in blood specimen above reference range


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:VH2XOU12IE


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: leukemia


subject: UNII:G8RGG88B68

object_name: childhood leukemia


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: UMLS:C0599934


subject: UNII:QPQ082R25D

subject_name: Islatravir

object_name: HIV infection


subject: CHEBI:230493

subject_name: pinometostat


subject: CHEBI:230493


subject: CHEBI:230493

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:230493

object_name: acute myeloid leukemia


subject: CHEBI:230493

object_name: acute leukemia


subject: CHEBI:230493

object_name: acute lymphoblastic leukemia


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: MESH:C583893


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hysteromyoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: adult glioblastoma


subject: CHEBI:141969

object_name: Adult Gliosarcoma


subject: CHEBI:141969

object_name: Adult Giant Cell Glioblastoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: corneal ulcer


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline


subject: CHEBI:31596

subject_name: Febuxostat

object_name: type 1 diabetes mellitus 1


subject: CHEBI:31596

object_name: type 1 diabetes mellitus


subject: UNII:QX4U8JPV3Z

object_name: type 2 diabetes mellitus


subject: UMLS:C2714892


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: bacterial vaginosis


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Uterine Inertia


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C4735074

subject_name: pine nut oil

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4735074

object_name: obesity


subject: UMLS:C4735074

object_name: Obesity, CTCAE


subject: CHEBI:46261

subject_name: Phenylthiourea

object_name: colorectal carcinoma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: palmoplantar keratosis


subject: CHEBI:114785

object_name: Palmoplantar keratoderma


subject: CHEBI:114785

object_name: epidermolytic ichthyosis


subject: CHEBI:114785

object_name: autosomal dominant epidermolytic ichthyosis


subject: CHEBI:114785

object_name: pachyonychia congenita


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: Increased reactive oxygen species production


subject: CHEBI:22198

object_name: end stage renal failure


subject: CHEBI:22198

object_name: Chronic uremia


subject: CHEBI:22198

object_name: arteriosclerosis disorder


subject: CHEBI:22198

object_name: atherosclerosis


subject: CHEBI:22198

object_name: anemia


subject: CHEBI:22198

object_name: Anemia, CTCAE


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: UMLS:C3851094

object_name: lupus nephritis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: hypertriglyceridemia


subject: CHEBI:39548

object_name: Hypertriglyceridemia, CTCAE


subject: UNII:H18SKU3289

subject_name: visilizumab

object_name: ulcerative colitis


subject: UNII:H18SKU3289

object_name: inflammatory bowel disease 1


subject: UMLS:C1135148

subject_name: Nuvion


subject: UMLS:C1135148


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: epilepsy


subject: CHEBI:5118

object_name: Sudden unexpected death in epilepsy


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: Mesothelioma


subject: UNII:M170940PMI

object_name: mesothelial neoplasm


subject: UNII:M170940PMI

object_name: malignant mesothelioma


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: UMLS:C3273944


subject: UMLS:C3273944


subject: UMLS:C5214487

subject_name: Antiplatelet

object_name: atrial fibrillation


subject: UMLS:C5214487

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C5214487

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:48923

subject_name: erythromycin

object_name: gastroparesis


subject: CHEBI:48923

object_name: Gastroparesis, CTCAE


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:136007

subject_name: methylnaltrexone


subject: CHEBI:136007


subject: CHEBI:39548

object_name: Foot Ulcer


subject: CHEBI:50663

subject_name: Zanamivir

object_name: influenza


subject: CHEBI:188153

subject_name: Oteseconazole

object_name: Recurrent vulvovaginal candidiasis


subject: CHEBI:73727

object_name: Renal artery stenosis


subject: UMLS:C0114857

subject_name: Dotarem


subject: UMLS:C3490643

subject_name: Pyridorin

object_name: diabetic kidney disease


subject: CHEBI:131532

subject_name: pyridoxamine dihydrochloride


subject: CHEMBL.COMPOUND:CHEMBL4298078

subject_name: PYRIDOXAMINE DIHYDROCHLORIDE


subject: CHEBI:135401

subject_name: Clofibride

object_name: Alzheimer disease


subject: UMLS:C0128362

subject_name: MG 46


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Adult bronchiectasis


subject: CHEBI:6456

object_name: Bronchopulmonary disease


subject: CHEBI:6456

object_name: Mediastinal lymphadenopathy


subject: CHEBI:6456

object_name: Infiltration


subject: CHEBI:6456

object_name: Chest--Diseases


subject: CHEBI:6456

object_name: pneumonia


subject: CHEBI:6456

object_name: COVID-19-Associated Pneumonia


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: post operative nausea and vomiting


subject: CHEBI:23965

subject_name: estradiol

object_name: schizoaffective disorder


subject: CHEBI:23965

object_name: schizophrenia 18


subject: CHEBI:23965

object_name: schizophrenia


subject: CHEBI:64816

object_name: bladder tumor


subject: CHEBI:64816

object_name: urinary bladder carcinoma


subject: CHEBI:64816

object_name: urinary bladder cancer


subject: CHEBI:64816

object_name: childhood bladder carcinoma


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEMBL.COMPOUND:CHEMBL2109092

subject_name: EPOETIN BETA

object_name: Myelodysplasia


subject: CHEBI:134990

subject_name: Agomelatine

object_name: fibromyalgia


subject: CHEBI:134990

object_name: major depressive disorder


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage II Colon Cancer


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: inherited lipid metabolism disorder


subject: DRUGBANK:DB05014

object_name: nonpapillary renal cell carcinoma


subject: DRUGBANK:DB05014

object_name: clear cell renal carcinoma


subject: DRUGBANK:DB05014

object_name: renal cell adenocarcinoma


subject: DRUGBANK:DB05014

object_name: renal cell carcinoma


subject: CHEBI:6456

object_name: respiratory failure


subject: CHEBI:6456

object_name: Respiratory Failure, CTCAE


subject: CHEBI:6456

object_name: Thoracic Injury


subject: CHEBI:6456

object_name: Chest pain


subject: PR:000012498

subject_name: protein disulfide-isomerase A3

object_name: Compulsion


subject: PR:000006871

subject_name: emopamil-binding protein-like


subject: PR:000007026

subject_name: ETS domain-containing protein Elk-3


subject: UMLS:C0056562

subject_name: crystalloid solutions

object_name: septic shock


subject: UMLS:C0056562

object_name: hypertension


subject: UMLS:C0056562

object_name: Hypertension, CTCAE


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: UMLS:C3828882

subject_name: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C3828882

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C3828882

object_name: Acute lymphoid leukemia in remission


subject: UMLS:C3828882

object_name: Acute myeloid leukemia in remission


subject: UMLS:C3828882

object_name: Myelodysplasia


subject: UMLS:C3828882

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3828882

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3828882

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3828882

object_name: myeloproliferative neoplasm


subject: UMLS:C3828882

object_name: Malignant myeloproliferative neoplasm


subject: UMLS:C3828882

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C3828882

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C3828882

object_name: non-Hodgkin lymphoma


subject: UMLS:C3828882

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C3828882

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3828882

object_name: Hodgkin Disease


subject: UMLS:C3828882

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C3828882

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C3828882

object_name: myelofibrosis


subject: CHEBI:135752

subject_name: Tafenoquine

object_name: infectious disease


subject: CHEBI:135752


subject: PUBCHEM.COMPOUND:3222

object_name: cancer


subject: PUBCHEM.COMPOUND:3222

object_name: neoplasm


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: PUBCHEM.COMPOUND:127021097

subject_name: RUZASVIR

object_name: chronic hepatitis C virus infection


subject: UNII:JW31KPS26S

subject_name: Uprifosbuvir


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: stroke disorder


subject: PUBCHEM.COMPOUND:11635624

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:11635624

object_name: Stroke (heart beat)


subject: PUBCHEM.COMPOUND:11635624

object_name: Stroke, CTCAE


subject: PUBCHEM.COMPOUND:11635624

object_name: Embolism


subject: PUBCHEM.COMPOUND:11635624

object_name: Embolus


subject: UMLS:C5908012

subject_name: Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314

object_name: metastatic colorectal cancer


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:25136944

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:25136944

object_name: breast cancer


subject: CHEBI:231679

subject_name: ipilimumab

object_name: skin neoplasm


subject: CHEBI:231679

object_name: skin cancer


subject: UNII:0H1IDR8Z4F

object_name: Depressed mood


subject: UNII:0H1IDR8Z4F

object_name: Cancer patients and suicide and depression


subject: UNII:0H1IDR8Z4F

object_name: Depressed - symptom


subject: UNII:0H1IDR8Z4F

object_name: Depression, CTCAE


subject: DRUGBANK:DB18904


subject: DRUGBANK:DB18904


subject: DRUGBANK:DB18904


subject: DRUGBANK:DB18904


subject: DRUGBANK:DB17891

subject_name: Fazirsiran

object_name: alpha 1-antitrypsin deficiency


subject: UMLS:C5815632

subject_name: ARO-AAT


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Cirrhosis


subject: CHEBI:9150

subject_name: Simvastatin

object_name: arteriosclerosis disorder


subject: CHEBI:9150

object_name: atherosclerosis


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Osteochondritis


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:85089

subject_name: Ledipasvir

object_name: type 2 diabetes mellitus


subject: CHEBI:85089

object_name: Insulin resistance


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:85083


subject: MESH:C499994

object_name: venous insufficiency


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: inflammatory bowel disease 1


subject: UNII:HM5641GA6F

object_name: Crohn disease


subject: UNII:HM5641GA6F

object_name: inflammatory bowel disease


subject: UMLS:C0537668

subject_name: Neumega


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C4705367

object_name: rheumatoid arthritis


subject: CHEBI:91464

object_name: SM-AHNMD


subject: CHEBI:91464

object_name: systemic mastocytosis


subject: CHEBI:91464

object_name: aggressive systemic mastocytosis


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: CHEBI:63452


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: liver carcinoma


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:66919

object_name: chronic myelomonocytic leukemia


subject: CHEBI:66919

object_name: Myelodysplasia, CTCAE


subject: CHEBI:66919

object_name: leukemia


subject: CHEBI:66919

object_name: childhood leukemia


subject: UMLS:C5238233

subject_name: Wee1 Inhibitor ZN-c3

object_name: adult acute myeloid leukemia


subject: UMLS:C5238233

object_name: childhood acute myeloid leukemia


subject: UMLS:C5238233

object_name: acute myeloid leukemia


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe

object_name: plasma cell myeloma


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: central nervous system infectious disorder


subject: UMLS:C0812735

object_name: Central Nervous System Fungal Infections


subject: UMLS:C0812735

object_name: fungal meningitis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: non-small cell lung carcinoma


subject: UMLS:C4054250

object_name: brain neoplasm


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: vasculitis


subject: CHEBI:168396

object_name: Vasculitis, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: chronic kidney disease


subject: PUBCHEM.COMPOUND:70789204

object_name: Chronic uremia


subject: UMLS:C0971122

subject_name: ICL 670A

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C0971122

object_name: aplastic anemia


subject: UMLS:C0971122

object_name: idiopathic aplastic anemia


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: UMLS:C4763426

subject_name: Tuparstobart


subject: UMLS:C4763426

object_name: triple-negative breast carcinoma


subject: UMLS:C4763426

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4763426

object_name: small cell lung carcinoma


subject: UMLS:C4763426

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C4763426

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4763426

object_name: liver carcinoma


subject: UMLS:C4763426

object_name: trabecular adenocarcinoma


subject: UMLS:C4763426

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4763426

object_name: urothelial carcinoma


subject: UMLS:C4763426

object_name: transitional cell carcinoma


subject: UMLS:C4763426

object_name: carcinoma of esophagus


subject: UMLS:C4763426

object_name: esophageal cancer


subject: UMLS:C4763426

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4763426

object_name: neoplasm of esophagus


subject: UMLS:C4763426

object_name: cervical cancer


subject: UMLS:C4763426

object_name: cervical carcinoma


subject: UMLS:C4763426

object_name: ovarian cancer


subject: UMLS:C4763426

object_name: ovarian neoplasm


subject: UMLS:C4763426

object_name: ovarian carcinoma


subject: UMLS:C4763426

object_name: Mesothelioma


subject: UMLS:C4763426

object_name: mesothelial neoplasm


subject: UMLS:C4763426

object_name: malignant mesothelioma


subject: UNII:1PON08459R

subject_name: ajmaline

object_name: Brugada syndrome


subject: UNII:1PON08459R

object_name: Brugada Syndrome Ventricular Arrhythmia by ECG Finding


subject: UNII:1PON08459R

object_name: Sudden death


subject: UNII:1PON08459R

object_name: Sudden Death Not Associated with More Specific CTCAE Term, CTCAE


subject: PUBCHEM.COMPOUND:2073

subject_name: Aritmina


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: PUBCHEM.COMPOUND:2073


subject: CHEBI:58567

subject_name: ajmalinium


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:58567


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: outcomes general quality of life


subject: CHEBI:46245

object_name: Perceived quality of life


subject: CHEBI:46245

object_name: Good quality of life


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C1095914

subject_name: reishi mushroom preparation


subject: UMLS:C1095914


subject: UMLS:C1095914


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Freezing of gait


subject: CHEBI:76016

object_name: Parkinson disease


subject: UNII:9N4Y2R43OM

subject_name: ILOFOTASE ALFA

object_name: pyropoikilocytosis, hereditary


subject: UNII:9N4Y2R43OM

object_name: hypophosphatasia


subject: UMLS:C5555460

subject_name: Recombinant human alkaline phosphatase


subject: UMLS:C5555460


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: UMLS:C3658787

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3658787

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:231679

subject_name: ipilimumab


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: hypertrophic cardiomyopathy


subject: PUBCHEM.COMPOUND:9800288

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: retinal vein occlusion


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:78140854

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:78140854

object_name: Malignant myeloproliferative neoplasm


subject: PUBCHEM.COMPOUND:78140854

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:78140854

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:78140854

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:78140854

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1170576

subject_name: Rebetol

object_name: hepatitis C


subject: CHEBI:6801

subject_name: Metformin

object_name: Muscle Atrophy


subject: UMLS:C0544354

subject_name: bacterial vaccines, mixed

object_name: Plexosarcoma


subject: UMLS:C0544354

object_name: Childhood Gastrointestinal Stromal Tumor


subject: UMLS:C0544354

object_name: transitional cell carcinoma


subject: UMLS:C0544354

object_name: Neck Carcinoma


subject: UMLS:C0544354

object_name: head and neck neoplasm


subject: UMLS:C0544354

object_name: head and neck cancer


subject: UMLS:C0544354

object_name: prostate carcinoma


subject: UMLS:C0544354

object_name: prostate cancer


subject: UMLS:C0544354

object_name: ovarian cancer


subject: UMLS:C0544354

object_name: ovarian carcinoma


subject: UMLS:C0544354

object_name: malignant epithelial tumor of ovary


subject: UMLS:C0544354

object_name: carcinoma of esophagus


subject: UMLS:C0544354

object_name: esophageal cancer


subject: UMLS:C0544354

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0544354

object_name: neoplasm of esophagus


subject: UMLS:C0544354

object_name: Childhood Breast Carcinoma


subject: UMLS:C0544354

object_name: breast carcinoma


subject: UMLS:C0544354

object_name: breast cancer


subject: UMLS:C0544354

object_name: melanoma


subject: UMLS:C0544354

object_name: malignant soft tissue neoplasm


subject: UMLS:C0544354

object_name: sarcoma


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT


subject: CHEMBL.COMPOUND:CHEMBL2108102


subject: CHEMBL.COMPOUND:CHEMBL2108102


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Hot Flashes, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108102

object_name: Hot flashes


subject: CHEBI:188074

object_name: Menopause present (finding)


subject: CHEBI:188074

object_name: Menopause


subject: CHEBI:188074

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:188074

object_name: obesity


subject: CHEBI:188074

object_name: Obesity, CTCAE


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:231324

subject_name: alpelisib

object_name: metastatic colorectal cancer


subject: CHEBI:231324

object_name: PIK3CA Gene Mutation


subject: PUBCHEM.COMPOUND:2781

subject_name: Meclastine

object_name: schizophrenia


subject: CHEBI:3738

subject_name: Clemastine


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Childhood Central Nervous System Teratoma


subject: CHEBI:52717

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:52717

object_name: childhood central nervous system germinoma


subject: CHEBI:52717

object_name: central nervous system endodermal sinus tumor


subject: CHEBI:52717

object_name: Recurrent Childhood Central Nervous System Embryonal Tumor


subject: CHEBI:52717

object_name: childhood central nervous system mixed germ cell tumor


subject: CHEBI:52717

object_name: pediatric CNS choriocarcinoma


subject: CHEBI:52717

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:52717

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:52717

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:52717

object_name: Recurrent Childhood Pineoblastoma


subject: CHEBI:52717

object_name: Recurrent Childhood Medulloblastoma


subject: CHEBI:52717

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:52717

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:52717

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:52717

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:52717

object_name: Burkitt lymphoma


subject: CHEBI:52717

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:52717

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:52717

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:52717

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:52717

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:52717

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:52717

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:52717

object_name: recurrent childhood visual pathway and hypothalamic glioma


subject: CHEBI:52717

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:52717

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: CHEBI:52717

object_name: childhood choroid plexus neoplasm


subject: CHEBI:52717

object_name: childhood medulloepithelioma


subject: CHEBI:52717

object_name: childhood oligodendroglioma


subject: CHEBI:52717

object_name: Childhood Craniopharyngioma


subject: CHEBI:52717

object_name: Childhood Mixed Glioma


subject: CHEBI:52717

object_name: pediatric meningioma


subject: CHEBI:45716

subject_name: Vorinostat

object_name: childhood central nervous system germ cell tumor


subject: CHEBI:45716

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Malignant Germ Cell Tumor


subject: CHEBI:45716

object_name: Burkitt lymphoma


subject: CHEBI:45716

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:45716

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:45716

object_name: Recurrent Childhood Grade III Lymphomatoid Granulomatosis


subject: CHEBI:45716

object_name: Childhood Diffuse Large Cell Lymphoma


subject: CHEBI:45716

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:45716

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:45716

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: CHEBI:45716


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: adhesions of uterus


subject: UMLS:C3274572

subject_name: Honey-containing Mouthwash

object_name: Neck Carcinoma


subject: UMLS:C3274572

object_name: head and neck neoplasm


subject: UMLS:C3274572

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: anemia


subject: DRUGBANK:DB17475

object_name: Anemia, CTCAE


subject: DRUGBANK:DB17475

object_name: Nutritional status


subject: CHEBI:94366

subject_name: itraconazole

object_name: basal cell carcinoma


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Melanoma recurrent


subject: CHEBI:145371

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:145371

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:34945

object_name: Chronic idiopathic constipation


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Cardiac amyloidosis


subject: CHEBI:85078

object_name: Heart failure with mid range ejection fraction


subject: CHEBI:85078

object_name: Heart failure with reduced ejection fraction


subject: UMLS:C3899497

subject_name: Copper Cu 64-DOTA-AE105

object_name: prostate carcinoma


subject: UMLS:C3899497

object_name: prostate cancer


subject: CHEBI:50853

subject_name: quantum dot

object_name: inherited lipid metabolism disorder


subject: UMLS:C5673367

subject_name: Diclofenac Sodium Solution

object_name: gingival recession


subject: UMLS:C5673367

object_name: Generalized gingival recession


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Advanced renal cell carcinoma


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:187888

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:187888

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:187888

object_name: neoplasm of esophagus


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Meniere disease


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib

object_name: chronic graft versus host disease


subject: PUBCHEM.COMPOUND:77256380

object_name: fasciitis


subject: UMLS:C5557249

subject_name: Anti-ALK-1 Monoclonal Antibody GT90001

object_name: Childhood Solid Neoplasm


subject: UMLS:C5557249

object_name: Adult Solid Neoplasm


subject: UMLS:C5557249

object_name: Solid Neoplasm


subject: UMLS:C4763757

subject_name: Erfonrilimab


subject: UMLS:C4763757


subject: UMLS:C4763757


subject: CHEBI:82717

subject_name: Tedizolid

object_name: bacterial infectious disease


subject: CHEBI:58097

object_name: cancer


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: CHEBI:7824

object_name: neoplasm


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: MESH:D000077324

subject_name: Crystalloid Solutions

object_name: malnutrition


subject: UMLS:C0056562

subject_name: crystalloid solutions


subject: UMLS:C4733480

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4730867

subject_name: Olopatadine Hydrochloride Ophthalmic Solution

object_name: atopic conjunctivitis


subject: UNII:1IJV77EI07

subject_name: Tepotinib

object_name: liver carcinoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: membranous glomerulonephritis


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Hypovolemia


subject: CHEBI:63627

subject_name: Tinidazole

object_name: trichomoniasis


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: DS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: ISS Stage I Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: ISS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: ISS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:73005958

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: CHEBI:73501

subject_name: Glu-Phe-Val

object_name: tuberculosis


subject: UMLS:C3467978

object_name: HIV infection


subject: CHEBI:75331

subject_name: benzotriazole

object_name: Urinary Urgency


subject: CHEBI:75331

object_name: Urinary Frequency or Urgency, CTCAE


subject: CHEBI:75331

object_name: urgency urinary incontinence


subject: UMLS:C0676494

subject_name: bladder tumor-associated antigen


subject: UMLS:C0676494


subject: UMLS:C0676494


subject: UMLS:C4742538

object_name: progressive supranuclear palsy


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: Graves disease


subject: CHEBI:135117

subject_name: ftivazide

object_name: pulmonary tuberculosis


subject: CHEBI:6030

subject_name: Isoniazid


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C0751599

subject_name: Betantrone

object_name: multiple sclerosis


subject: UMLS:C0015980

subject_name: interferon-beta


subject: UMLS:C4310525

object_name: retinitis pigmentosa


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: central congenital hypothyroidism


subject: UMLS:C1881373

object_name: isolated thyroid-stimulating hormone deficiency


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UMLS:C1812819

subject_name: Kemstro


subject: CHEBI:187893

subject_name: Baclofen


subject: UMLS:C5708226

subject_name: Gallium Ga 68-labeled Tilmanocept

object_name: endometrial cancer


subject: UMLS:C5708226

object_name: uterine corpus cancer


subject: UMLS:C5708226

object_name: endometrial carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: viral pneumonia


subject: CHEMBL.COMPOUND:CHEMBL2108388

subject_name: FERUCARBOTRAN

object_name: acute myocardial infarction


subject: CHEMBL.COMPOUND:CHEMBL2108388

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0286706

subject_name: Resovist


subject: UMLS:C0286706


subject: CHEBI:6456

subject_name: Lidocaine

object_name: fibromyalgia


subject: GTOPDB:6930

subject_name: bapineuzumab

object_name: Alzheimer disease type 1


subject: GTOPDB:6930

object_name: Alzheimer disease


subject: UNII:NC11WKO35D


subject: UNII:NC11WKO35D


subject: UMLS:C2698328


subject: UMLS:C2698328


subject: CHEBI:30769

subject_name: Citric acid

object_name: liver failure


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: liver cancer


subject: GTOPDB:9592

object_name: liver neoplasm


subject: GTOPDB:9592

object_name: Adult Liver Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: B-cell lymphoma refractory


subject: CHEBI:91397

object_name: B-cell lymphoma recurrent


subject: CHEBI:91397

object_name: Burkitt's lymphoma refractory


subject: CHEBI:91397

object_name: mediastinal malignant lymphoma


subject: CHEBI:91397

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:91397

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:91397

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:91397

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: CHEBI:91397

object_name: Lymphoma, Mixed-Cell, Follicular


subject: CHEBI:91397

object_name: B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


subject: CHEBI:91397

object_name: grade 3A follicular lymphoma


subject: CHEBI:91397


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Mantle cell lymphoma refractory


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Follicular lymphoma refractory


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:DPT0O3T46P

object_name: Mantle cell lymphoma recurrent


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Marginal zone lymphoma recurrent


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Follicular lymphoma recurrent


subject: UNII:DPT0O3T46P

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:231005

object_name: uterine carcinosarcoma


subject: CHEBI:231005

object_name: ovarian carcinosarcoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:PTC2969MV1

subject_name: Halofuginone Hydrobromide

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0521922

subject_name: Halofuginone hydrobromide


subject: UMLS:C1268859

subject_name: Zinc supplement

object_name: Inflammation


subject: UMLS:C1268859

object_name: Zinc excess


subject: UMLS:C1268859

object_name: Zinc deficiency


subject: UMLS:C1268859

object_name: Dyslipidemia


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:141969

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:141969

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:141969

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:141969

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: absorption; chemicals


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: precancerous condition


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C4053601


subject: UMLS:C5667019

subject_name: Anti-PSMA/CD3 Bispecific Antibody REGN4336


subject: UMLS:C5206865

subject_name: Nezastomig


subject: UNII:NU90V55F8I

subject_name: Sarilumab


subject: RXCUI:798361

subject_name: Havrix

object_name: Japanese encephalitis


subject: CHEBI:80271

subject_name: Glp-2 [MI]

object_name: inherited lipid metabolism disorder


subject: CHEBI:80271


subject: UMLS:C0912332

subject_name: Glucagon-Like Peptide 2


subject: UMLS:C0912332


subject: CHEBI:41060

subject_name: IBANDRONATE

object_name: osteoporosis


subject: CHEBI:41060

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:41060

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:41060

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:UMD7G2653W

subject_name: Ibandronate


subject: UNII:UMD7G2653W


subject: UNII:UMD7G2653W


subject: UNII:UMD7G2653W


subject: UNII:JJX4JHS4PO

object_name: malignant pleural mesothelioma


subject: UMLS:C2346687


subject: UMLS:C0022478

subject_name: kininogenase

object_name: Acute Stroke


subject: UMLS:C5551415

subject_name: Kallikrein


subject: GTOPDB:8221

subject_name: epacadostat

object_name: lung cancer


subject: GTOPDB:8221

object_name: lung neoplasm


subject: GTOPDB:8221

object_name: lung carcinoma


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Hypotension during surgery


subject: CHEBI:33569

object_name: no feeling or sensation of skin


subject: CHEBI:33569

object_name: Sensory Loss


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093

object_name: acute kidney failure


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: coronary artery disorder


subject: CHEBI:94518

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:20642899

subject_name: ZOLUNICANT

object_name: Addiction


subject: UNII:KX8NQX91Z8


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: RXCUI:1592713

subject_name: Xigduo

object_name: type 2 diabetes mellitus


subject: UMLS:C5420249

subject_name: Extended Release Metformin Hydrochloride


subject: MESH:D013607

subject_name: Tablets


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: CHEBI:93786


subject: CHEBI:83766

subject_name: Olaparib

object_name: Breast cancer recurrent


subject: CHEBI:83766

object_name: Metastatic malignant neoplasm to chest wall


subject: CHEBI:133351

subject_name: hydantoic acid

object_name: Melasma


subject: CHEBI:17497

subject_name: Glycolic acid


subject: CHEBI:30956

subject_name: trichloroacetic acid


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: subarachnoid hemorrhage


subject: UMLS:C3898831

object_name: traumatic encephalopathy


subject: UMLS:C3898831

object_name: traumatic brain injury


subject: UMLS:C2346820

object_name: rhabdoid tumor


subject: CHEBI:16796

subject_name: Melatonin

object_name: pain agnosia


subject: CHEBI:16796

object_name: Pain insensitivity


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:45863

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:135945

subject_name: Pixantrone

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:135945

object_name: non-Hodgkin lymphoma


subject: CHEBI:16236

subject_name: Ethanol

object_name: prostate disorder


subject: CHEBI:16236

object_name: benign prostatic hyperplasia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Renal Function


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:59905


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:6801

subject_name: Metformin

object_name: Carcinoma breast stage IV


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Hemodynamic stability


subject: CHEBI:16480

object_name: Collapsed Lung


subject: CHEBI:16480

object_name: pneumothorax


subject: CHEBI:16480

object_name: Atelectasis


subject: UMLS:C4287766


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: glycogen storage disease I


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Chimera (disorder)


subject: CHEBI:4026

object_name: Disorder of transplanted kidney


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: kidney failure


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:KUW1QG1ZM3

subject_name: siplizumab


subject: UNII:KUW1QG1ZM3


subject: UMLS:C1310928


subject: UMLS:C1310928


subject: UNII:RRN67GMB0V

subject_name: Elexacaftor

object_name: cystic fibrosis


subject: UNII:8RW88Y506K

subject_name: Tezacaftor


subject: MESH:C000610984

subject_name: co-ultraPEALut

object_name: traumatic encephalopathy


subject: MESH:C000610984

object_name: traumatic brain injury


subject: CHEBI:36373

subject_name: vindesine

object_name: leukemia


subject: CHEBI:36373

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: fibromyalgia


subject: PUBCHEM.COMPOUND:13175121

object_name: ovarian endometriosis


subject: CHEBI:50172

subject_name: acitretin

object_name: psoriasis


subject: CHEBI:50174


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Invasive pulmonary aspergillosis


subject: UNII:1EJT54415A

subject_name: Ligandrol

object_name: Control of hip fracture risk


subject: UNII:1EJT54415A

object_name: hip fracture


subject: CHEBI:7465

subject_name: Naltrexone


subject: UMLS:C5198735

object_name: rheumatoid arthritis


subject: UMLS:C1320098

subject_name: Risperdal Consta

object_name: schizophrenia


subject: MESH:D013607

subject_name: Tablets

object_name: Myocardial injury


subject: MESH:D013607

object_name: acute myocardial infarction


subject: MESH:D013607

object_name: Acute Myocardial Infarction by ECG Finding


subject: MESH:D013607

object_name: MINOCA


subject: CHEBI:94843

subject_name: Vicriviroc

object_name: AIDS


subject: CHEBI:6801

subject_name: Metformin

object_name: breast neoplasm


subject: CHEBI:15365

subject_name: Aspirin

object_name: peripheral vascular disease


subject: CHEBI:15365

object_name: peripheral arterial disease


subject: UMLS:C1831904

subject_name: ThermoDox

object_name: liver neoplasm


subject: CHEBI:36704

subject_name: Imiquimod

object_name: basal cell carcinoma


subject: CHEBI:36704

object_name: skin basal cell carcinoma


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:47458

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:47458

object_name: Rectal cancer stage IV


subject: CHEBI:47458

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:47458

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:47458

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:47458

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:47458

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:47458

object_name: Recurrent Rectal Cancer


subject: CHEBI:47458

object_name: Colon cancer recurrent


subject: CHEBI:47458

object_name: colon adenocarcinoma


subject: CHEBI:47458

object_name: rectum adenocarcinoma


subject: UNII:2P987FW4E8

object_name: clostridium difficile infection


subject: UMLS:C4547458


subject: CHEBI:195559

subject_name: Poziotinib

object_name: EGFR Exon 20 Mutation


subject: CHEBI:195559

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:195559

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:195559

object_name: ERBB2 Gene Mutation


subject: CHEBI:125535

subject_name: Esreboxetine

object_name: fibromyalgia


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Irregular menstruation


subject: MESH:D000086663

object_name: menopausal bleeding


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C0879272

object_name: Carcinoma breast stage IV


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:64816


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: chronic leukemia


subject: CHEBI:28887

subject_name: Ofatumumab


subject: UMLS:C1541395


subject: CHEBI:7852

subject_name: Oxycodone

object_name: herpes zoster


subject: CHEBI:7852

object_name: postherpetic neuralgia


subject: CHEBI:64816

object_name: Neoplasm Metastasis


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:231681

subject_name: olaratumab


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Consent Type - Hysterectomy


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:10056

subject_name: Xanomeline

object_name: Alzheimer disease type 1


subject: CHEBI:10056

object_name: Alzheimer disease


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: intraocular lymphoma


subject: CHEBI:175901

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:175901

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:175901

object_name: Mantle cell lymphoma stage III


subject: CHEBI:175901

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:175901

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:175901

object_name: anaplastic large cell lymphoma


subject: CHEBI:175901

object_name: small intestine lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:175901

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:175901

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:175901

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:175901

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:175901

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:175901

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:175901

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:175901

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:175901

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:175901

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:175901

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:175901

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:175901

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:175901

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:175901

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:175901

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:175901

object_name: splenic marginal zone lymphoma


subject: CHEBI:175901

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:175901

object_name: MALT lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:175901

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:175901

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:175901

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Marginal zone lymphoma stage III


subject: CHEBI:175901

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:175901

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:175901

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:175901

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:175901

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:175901

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:175901

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:175901

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:175901

object_name: primary central nervous system Hodgkin lymphoma


subject: CHEBI:175901

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:175901

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:175901

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:175901

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:231347

subject_name: Triapine

object_name: intraocular lymphoma


subject: CHEBI:231347

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:231347

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:231347

object_name: Mantle cell lymphoma stage III


subject: CHEBI:231347

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:231347

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:231347

object_name: anaplastic large cell lymphoma


subject: CHEBI:231347

object_name: small intestine lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:231347

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:231347

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:231347

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:231347

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:231347

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:231347

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:231347

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:231347

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:231347

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:231347

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:231347

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:231347

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:231347

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:231347

object_name: angioimmunoblastic T-cell lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:231347

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:231347

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:231347

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:231347

object_name: splenic marginal zone lymphoma


subject: CHEBI:231347

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:231347

object_name: MALT lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:231347

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:231347

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:231347

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:231347

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:231347

object_name: Marginal zone lymphoma stage III


subject: CHEBI:231347

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231347

object_name: recurrent cutaneous T-cell lymphoma


subject: CHEBI:231347

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:231347

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:231347

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231347

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:231347

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:231347

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:231347

object_name: primary central nervous system Hodgkin lymphoma


subject: CHEBI:231347

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:231347

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: CHEBI:231347

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:231347

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:45716

object_name: Mantle cell lymphoma stage III


subject: CHEBI:45716

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:45716

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:45716

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:45716

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:45716

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:45716

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:45716

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:45716

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:45716

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:45716

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:45716

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:45716

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:45716

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:45716

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:45716

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:45716

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:45716

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Marginal zone lymphoma stage III


subject: CHEBI:45716

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:45716

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:45716

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:45716

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:45716

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:45716

object_name: primary central nervous system Hodgkin lymphoma


subject: CHEBI:45716

object_name: central nervous system non-hodgkin lymphoma


subject: CHEBI:45716

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: nephrolithiasis, calcium oxalate


subject: CHEBI:9398

object_name: nephrolithiasis


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: stroke disorder


subject: CHEBI:70746

object_name: cerebrovascular disorder


subject: CHEBI:70746

object_name: Stroke (heart beat)


subject: CHEBI:70746

object_name: Stroke, CTCAE


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:71952

subject_name: Dactolisib

object_name: endometrial cancer


subject: CHEBI:71952

object_name: uterine corpus cancer


subject: CHEBI:71952

object_name: endometrial carcinoma


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: periodontal disorder


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:17688

subject_name: Nicotine

object_name: Neck Carcinoma


subject: CHEBI:17688

object_name: head and neck neoplasm


subject: CHEBI:17688

object_name: head and neck cancer


subject: CHEBI:17688

object_name: carcinoma of esophagus


subject: CHEBI:17688

object_name: esophageal cancer


subject: CHEBI:17688

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:17688

object_name: neoplasm of esophagus


subject: PR:000003493

subject_name: granzyme F

object_name: Gliosarcoma of brain


subject: PR:000003493

object_name: anaplastic astrocytoma


subject: PR:000003493

object_name: glioblastoma


subject: PR:000003493

object_name: Adult Gliosarcoma


subject: PR:000003493

object_name: Childhood Glioblastoma


subject: PR:000003493

object_name: adult glioblastoma


subject: PR:000003493

object_name: Childhood Astrocytoma


subject: PR:000003493

object_name: glioma susceptibility 1


subject: PR:000003493

object_name: astrocytic tumor


subject: PR:000003493

object_name: astrocytoma


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: end stage renal failure


subject: UNII:E3B2GI648A

object_name: Chronic uremia


subject: CHEBI:6121

subject_name: Ketamine

object_name: Injury


subject: CHEBI:6121

object_name: Trauma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: type 2 diabetes mellitus


subject: CHEBI:201431

object_name: diabetic kidney disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: Tendinopathy


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: diabetic neuropathy


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:3566

subject_name: cetylpyridinium chloride monohydrate

object_name: periodontitis


subject: CHEBI:3566

object_name: Premature birth


subject: CHEBI:32914

subject_name: Cetylpyridinium


subject: CHEBI:32914


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Other osteoporosis


subject: UMLS:C1869204

subject_name: PTC 124

object_name: cystic fibrosis


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: lung cancer


subject: GTOPDB:11376

object_name: lung neoplasm


subject: GTOPDB:11376

object_name: lung carcinoma


subject: GTOPDB:11376

object_name: cancer


subject: GTOPDB:11376

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEBI:45716

subject_name: Vorinostat

object_name: uterine carcinosarcoma


subject: CHEBI:45716

object_name: endometrial stromal tumor


subject: CHEBI:45716

object_name: leiomyosarcoma


subject: CHEBI:45716

object_name: Childhood Leiomyosarcoma


subject: CHEBI:45716

object_name: Adult Leiomyosarcoma


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: inherited lipid metabolism disorder


subject: DRUGBANK:DB11357

object_name: Dyslipidemia


subject: DRUGBANK:DB11357

object_name: hypertension


subject: DRUGBANK:DB11357

object_name: Hypertension, CTCAE


subject: CHEBI:36560

subject_name: Zinc oxide

object_name: Depressed mood


subject: CHEBI:36560

object_name: Cancer patients and suicide and depression


subject: CHEBI:36560

object_name: Depressed - symptom


subject: CHEBI:36560

object_name: Depression, CTCAE


subject: CHEBI:36560

object_name: anxiety


subject: CHEBI:36560

object_name: anxiety disorder


subject: CHEBI:36560

object_name: Anxiety symptoms


subject: CHEBI:36560

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:36560

object_name: Anxiety, CTCAE 5.0


subject: PUBCHEM.COMPOUND:18604758

object_name: progressive supranuclear palsy


subject: UMLS:C3501427


subject: CHEBI:8869

object_name: Weight loss


subject: CHEBI:8869

object_name: Weight Loss, CTCAE


subject: CHEBI:8869

object_name: bariatric surgery candidate


subject: CHEBI:8887

subject_name: Rofecoxib

object_name: hemophilic arthropathy


subject: CHEBI:233577

subject_name: Ranirestat

object_name: diabetic neuropathy


subject: UMLS:C0758745


subject: UNII:K9SP3L3YQP

subject_name: Rocacetrapib

object_name: inherited lipid metabolism disorder


subject: UNII:K9SP3L3YQP

object_name: Dyslipidemia


subject: CHEBI:184910

subject_name: Rotigotine

object_name: Restless legs


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: malignant mesothelioma


subject: CHEBI:32682

subject_name: L-argininium

object_name: rheumatoid arthritis


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C4525627

object_name: hematologic disorder


subject: CHEBI:177770

subject_name: Ganetespib

object_name: ovarian cancer


subject: CHEBI:177770

object_name: ovarian neoplasm


subject: CHEBI:177770

object_name: ovarian carcinoma


subject: CHEBI:177770

object_name: primary peritoneal carcinoma


subject: CHEBI:177770

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:177770

object_name: peritoneal carcinoma


subject: CHEBI:177770

object_name: fallopian tube carcinoma


subject: CHEBI:177770

object_name: fallopian tube cancer


subject: UNII:47RRR83SK7

subject_name: [OBSOLETE] interferon alfa-2a

object_name: hepatitis C


subject: UNII:47RRR83SK7

object_name: chronic hepatitis C virus infection


subject: CHEMBL.COMPOUND:CHEMBL2108508

subject_name: INTERFERON ALFA-2A


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: UMLS:C0021734

subject_name: Roferon-A


subject: UMLS:C0021734


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:8228


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: nasopharyngeal neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: major depressive disorder


subject: CHEBI:60802

subject_name: ropivacaine

object_name: spinal stenosis


subject: CHEBI:60802

object_name: spinal disease


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: pain agnosia


subject: UMLS:C3540792

object_name: Pain insensitivity


subject: UMLS:C3540792

object_name: Post-Operative Pain


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriatic arthritis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: atrial fibrillation


subject: CHEBI:9241

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:9241

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:66910

subject_name: Axitinib

object_name: endometriosis


subject: CHEBI:66910

object_name: Endometriosis externa


subject: CHEBI:66910

object_name: ovarian endometriosis


subject: CHEBI:66910

object_name: Endometriosis of rectum


subject: UMLS:C4083270

subject_name: BIBW 2992


subject: UMLS:C4083270


subject: UMLS:C4083270


subject: UMLS:C4083270


subject: CHEBI:91435

subject_name: Linifanib


subject: CHEBI:91435


subject: CHEBI:91435


subject: CHEBI:91435


subject: UMLS:C1737951

subject_name: linifanib


subject: UMLS:C1737951


subject: UMLS:C1737951


subject: UMLS:C1737951


subject: CHEBI:16919

subject_name: Creatine

object_name: fibromyalgia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hypochondroplasia


subject: UNII:I284LJY110

subject_name: Radotinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:2639

subject_name: Amiloride

object_name: migraine with aura


subject: MESH:D010919

subject_name: Placebos


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: pulmonary tuberculosis


subject: HMDB:HMDB0015332

subject_name: Rifapentine


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C5432205

subject_name: bupivacaine / meloxicam

object_name: Surgical incision wound (morphologic abnormality)


subject: UMLS:C5432205

object_name: Surgical wound


subject: UMLS:C5432205

object_name: physical trauma to surgical incision (history)


subject: UMLS:C5432205

object_name: vulvodynia


subject: UMLS:C5432205

object_name: Stress urinary incontinence


subject: UNII:39HBQ4A67L

subject_name: Mobocertinib

object_name: Hepatic impairment


subject: CHEBI:8499

subject_name: Propranolol

object_name: Dependence


subject: CHEBI:135901

subject_name: lanreotide

object_name: neuroendocrine neoplasm


subject: UMLS:C0051846

subject_name: angiopeptin


subject: PUBCHEM.COMPOUND:152165

object_name: osteoarthritis


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate

object_name: Frailty


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:6801

subject_name: Metformin

object_name: beta thalassemia major anemia


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Pregnant


subject: CHEBI:6950

object_name: hyperemesis gravidarum


subject: UMLS:C5856211

subject_name: Copper Cu 64 NODAGA-TTX-MC138

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:149836

subject_name: Tigecycline

object_name: peritonitis


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: hepatobiliary neoplasm


subject: UMLS:C3827082


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: esophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: Childhood Esophageal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: biliary tract cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: gastroesophageal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297562


subject: CHEMBL.COMPOUND:CHEMBL4297562

object_name: liver carcinoma


subject: UMLS:C3274547

subject_name: Sirexatamab


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: UMLS:C3274547


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: melanoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:29228

subject_name: FLUORIDE

object_name: gingivitis


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: esophageal adenocarcinoma


subject: UNII:6A901E312A

object_name: lung adenocarcinoma


subject: UNII:6A901E312A

object_name: cervical adenocarcinoma


subject: UNII:6A901E312A

object_name: adenocarcinoma


subject: UNII:6A901E312A

object_name: bile duct adenocarcinoma


subject: UNII:6A901E312A

object_name: gastric adenocarcinoma


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A

object_name: Gastroesophageal junction cancer


subject: UMLS:C5392756

object_name: cystic fibrosis


subject: UMLS:C5959394

subject_name: PARG Inhibitor ETX-19477

object_name: ovarian carcinoma


subject: UMLS:C5959394

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5959394

object_name: BRCA Gene Mutation


subject: UMLS:C5959394

object_name: BRCA1 gene mutation


subject: UMLS:C5959394

object_name: BRCA2 gene mutation


subject: UMLS:C5959394

object_name: prostate carcinoma


subject: UMLS:C5959394

object_name: prostate cancer


subject: UMLS:C5959394

object_name: endometrial cancer


subject: UMLS:C5959394

object_name: uterine corpus cancer


subject: UMLS:C5959394

object_name: endometrial carcinoma


subject: UMLS:C5959394

object_name: colorectal cancer


subject: UMLS:C5959394

object_name: colorectal carcinoma


subject: UMLS:C5959394

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5959394

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C5959394

object_name: Stomach cancer


subject: UMLS:C5959394

object_name: gastric cancer


subject: UMLS:C5959394

object_name: ovarian cancer


subject: UMLS:C5959394

object_name: ovarian neoplasm


subject: UMLS:C5959394

object_name: Childhood Breast Carcinoma


subject: UMLS:C5959394

object_name: breast carcinoma


subject: UMLS:C5959394

object_name: breast cancer


subject: DRUGBANK:DB10499

subject_name: Felis catus hair

object_name: Allergy


subject: DRUGBANK:DB10499

object_name: History of allergies


subject: UMLS:C1443200

subject_name: Cat hair antigen


subject: UMLS:C1443200


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: classic familial adenomatous polyposis


subject: CHEBI:43602

object_name: Adenomatous colonic polyposis


subject: CHEBI:43602

object_name: attenuated familial adenomatous polyposis


subject: CHEBI:43602


subject: CHEBI:43602

object_name: Duodenal Cancer


subject: CHEBI:43602

object_name: carcinoma of duodenum


subject: CHEBI:31401

subject_name: Cilostazol

object_name: migraine


subject: CHEBI:31401

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: non-24-hour sleep-wake syndrome


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: peritoneum cancer


subject: PUBCHEM.COMPOUND:43805

object_name: appendix carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:135964

subject_name: Clevudine

object_name: hepatitis B


subject: CHEBI:70707

subject_name: Vilazodone

object_name: sexual disorder


subject: CHEBI:70707

object_name: physiological sexual disorder


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: pneumonia


subject: PUBCHEM.COMPOUND:126456119

object_name: COVID-19-Associated Pneumonia


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C5555581

subject_name: Inetetamab

object_name: non-small cell lung carcinoma


subject: GTOPDB:8221

subject_name: epacadostat

object_name: head and neck squamous cell carcinoma


subject: UNII:2HR315841W


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Grade III Childhood Astrocytoma


subject: UNII:16VY3TM7ZO

object_name: Adult Anaplastic Astrocytoma


subject: UNII:16VY3TM7ZO

object_name: anaplastic astrocytoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495